Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Minshall

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Medical Care|April 27, 1999
Pharmacoeconomics research credibility: a controversial and recurring theme in health outcomes researchM E Minshall, M C Kody, F Mosbacher
Applied Health Economics and Health Policy|June 29, 2010
Cost effectiveness of insulin glargine plus oral antidiabetes drugs compared with premixed insulin alone in patients with type 2 diabetes mellitus in CanadaSandra L Tunis, Luc Sauriol, Michael E Minshall
The American Journal of Managed Care|September 15, 2009
Cost-effectiveness of Roux-en-Y gastric bypass in type 2 diabetes patientsSayeed Ikramuddin, David Klingman, Therese Swan, et al.
Journal of Clinical Movement Disorders|May 8, 2020
Objective measurement in Parkinson's disease: a descriptive analysis of Parkinson's symptom scores from a large population of patients across the world using the Personal KinetiGraph®Rajesh Pahwa, Filip Bergquist, Malcolm Horne, et al.
Canadian Journal of Physiology and Pharmacology|July 1, 1997
Heterogeneity of responsiveness of individual airways in cultured lung explantsE Minshall, C G Wang, R Dandurand, et al.
Journal of Managed Care Pharmacy : JMCP|January 26, 2007
Application of economic analyses in U.S. managed care formulary decisions: a private payer's experienceJohn B Watkins, Michael E Minshall, Sean D Sullivan
Journal of Medical Economics|April 22, 2024
Impact of <i>Pseudomonas aeruginosa</i> on resource utilization and costs in patients with exacerbated non-cystic fibrosis bronchiectasisMeg Franklin, Michael E Minshall, Federica Pontenani, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 28, 2009
A cost-effectiveness analysis of continuous subcutaneous insulin injection versus multiple daily injections in type 1 diabetes patients: a third-party US payer perspectiveMeaghan St Charles, Peter Lynch, Claudia Graham, et al.
British Journal of Pharmacology|July 1, 1994
The effect of allosteric antagonists in modulating muscarinic M2-receptor function in guinea-pig isolated tracheaD Spina, E Minshall, R G Goldie, et al.
British Journal of Pharmacology|December 1, 1990
Effects of several potassium channel openers and glibenclamide on the uterus of the ratI Piper, E Minshall, S J Downing, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Medical Care|April 27, 1999
Pharmacoeconomics research credibility: a controversial and recurring theme in health outcomes researchM E Minshall, M C Kody, F Mosbacher
Applied Health Economics and Health Policy|June 29, 2010
Cost effectiveness of insulin glargine plus oral antidiabetes drugs compared with premixed insulin alone in patients with type 2 diabetes mellitus in CanadaSandra L Tunis, Luc Sauriol, Michael E Minshall
The American Journal of Managed Care|September 15, 2009
Cost-effectiveness of Roux-en-Y gastric bypass in type 2 diabetes patientsSayeed Ikramuddin, David Klingman, Therese Swan, et al.
Journal of Clinical Movement Disorders|May 8, 2020
Objective measurement in Parkinson's disease: a descriptive analysis of Parkinson's symptom scores from a large population of patients across the world using the Personal KinetiGraph®Rajesh Pahwa, Filip Bergquist, Malcolm Horne, et al.
Canadian Journal of Physiology and Pharmacology|July 1, 1997
Heterogeneity of responsiveness of individual airways in cultured lung explantsE Minshall, C G Wang, R Dandurand, et al.
Journal of Managed Care Pharmacy : JMCP|January 26, 2007
Application of economic analyses in U.S. managed care formulary decisions: a private payer's experienceJohn B Watkins, Michael E Minshall, Sean D Sullivan
Journal of Medical Economics|April 22, 2024
Impact of <i>Pseudomonas aeruginosa</i> on resource utilization and costs in patients with exacerbated non-cystic fibrosis bronchiectasisMeg Franklin, Michael E Minshall, Federica Pontenani, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 28, 2009
A cost-effectiveness analysis of continuous subcutaneous insulin injection versus multiple daily injections in type 1 diabetes patients: a third-party US payer perspectiveMeaghan St Charles, Peter Lynch, Claudia Graham, et al.
British Journal of Pharmacology|July 1, 1994
The effect of allosteric antagonists in modulating muscarinic M2-receptor function in guinea-pig isolated tracheaD Spina, E Minshall, R G Goldie, et al.
British Journal of Pharmacology|December 1, 1990
Effects of several potassium channel openers and glibenclamide on the uterus of the ratI Piper, E Minshall, S J Downing, et al.
Pageof 6